GLP-1 Clinical Relevance #41Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical TrialPhase 3 TrialAlzheimer’s DiseaseSemaglutideNeurologyAdults with Cognitive DeclineCognitive OutcomesNeuroinflammation PathwayOral SemaglutideGLP-1 CNS EffectsNovo Nordisk PipelineEVOKE...
A Health Technology Assessment of Medical Cannabis: Clinical and Economic … – MacSphere
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Health EconomicsEvidence SynthesisInsurance CoverageClinical GuidelinesHealthcare Policy Why This MattersHealth technology assessments represent the gold...
What Does the Evidence Really Say About Cannabis Risks and Medical Benefits?
Chronic patterns of cannabis use have been associated with multiple adverse outcomes that are of particular concern among adolescents and young adults, such as disrupted learning, impaired cognitive performance, reduced educational attainment and an increased risk of CUD, psychosis/schizophrenia, mood and anxiety disorders and suicidal behaviors.